Wells Fargo & Company Raises Sabra Healthcare REIT (NASDAQ:SBRA) Price Target to $22.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price increased by Wells Fargo & Company from $21.00 to $22.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price would indicate a potential upside of 12.19% from the company’s current price.

Several other equities analysts have also recently commented on the stock. Cantor Fitzgerald lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 17th. Wall Street Zen lowered Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Citigroup increased their price target on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, February 18th. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Finally, Weiss Ratings raised Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Wednesday, March 18th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $22.00.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $19.61 on Thursday. The company has a fifty day moving average price of $19.79 and a 200-day moving average price of $19.07. The firm has a market cap of $4.94 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.56 and a beta of 0.64. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. Sabra Healthcare REIT has a 1 year low of $15.75 and a 1 year high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. During the same period in the previous year, the business earned $0.36 earnings per share. The firm’s revenue for the quarter was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities research analysts predict that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of hedge funds have recently modified their holdings of the stock. Rothschild Investment LLC lifted its stake in Sabra Healthcare REIT by 164.6% in the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 889 shares during the last quarter. Smartleaf Asset Management LLC increased its position in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares during the last quarter. Founders Capital Management purchased a new stake in Sabra Healthcare REIT in the third quarter worth $28,000. Strengthening Families & Communities LLC bought a new stake in shares of Sabra Healthcare REIT in the fourth quarter valued at $29,000. Finally, Danske Bank A S purchased a new position in shares of Sabra Healthcare REIT during the 3rd quarter valued at $30,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.